Biological characteristics of renal cancer cells after CTP-mediated cancer suppressor gene NPRL2 protein treatment

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Biological chemistry

• Publication date

  2016-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1515/hsz-2016-0143PMID 27186678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2016

  2016cited by this paper
• Functional characterization of the nitrogen permease regulator-like-2 candidate tumor suppressor gene in colorectal cancer cell lines

  2015cited by this paper
• TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

  2015cited by this paper
• Relationship between tumor and peripheral blood NPRL2 mRNA levels in patients with colorectal adenoma and colorectal cancer

  2014cited by this paper
• Decreased Expression of NPRL2 in Renal Cancer Cells is Associated with Unfavourable Pathological, Proliferation and Apoptotic Features

  2014cited by this paper
• Intracellular-delivery of a single-chain antibody against hepatitis B core protein via cell-penetrating peptide inhibits hepatitis B virus replication in vitro.

  2013cited by this paper
• NPRL2 is an independent prognostic factor of osteosarcoma

  2012cited by this paper
• Proliferative and Antiapoptotic Signaling Stimulated by Nuclear-Localized PDK1 Results in Oncogenesis

  2012cited by this paper
• Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma.

  2010cited by this paper
• Cloning, expression, purification and functional characterization of the oligomerization domain of Bcr-Abl oncoprotein fused to the cytoplasmic transduction peptide.

  2009cited by this paper
• The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor

  2009cited by this paper
• TUSC4/NPRL2, a novel PDK1‐interacting protein, inhibits PDK1 tyrosine phosphorylation and its downstream signaling

  2008cited by this paper
• RXP-E: A Connexin43-Binding Peptide That Prevents Action Potential Propagation Block

  2008cited by this paper
• Cytoplasmic transduction peptide (CTP): new approach for the delivery of biomolecules into cytoplasm in vitro and in vivo.

  2006cited by this paper
• Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence.

  2006cited by this paper
• Functional Characterization of the Candidate Tumor Suppressor Gene NPRL2/G21 Located in 3p21.3C

  2004cited by this paper
• The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

  2000cited by this paper

• Transcriptional signatures of the BCL2 family for individualized acute myeloid leukaemia treatment

  2022cites this paper
• Effect of CTP-mediated PTEN on 5637 bladder cancer cells and the underlying molecular mechanism

  2022cites this paper
• Nitrogen Permease Regulator-Like-2 Exhibited Anti-Tumor Effects And Enhanced The Sensitivity Of Colorectal Cancer Cells To Oxaliplatin And 5-Fluorouracil

  2019cites this paper
• OTT_A_219562 8637..8644

  2019cites this paper
• High expression of NPRL2 is linked to poor prognosis in patients with prostate cancer.

  2018cites this paper